FURLANUT, Mario
 Distribuzione geografica
Continente #
NA - Nord America 6.234
EU - Europa 1.427
AS - Asia 369
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 3
SA - Sud America 3
Totale 8.041
Nazione #
US - Stati Uniti d'America 6.193
UA - Ucraina 543
DE - Germania 237
CN - Cina 215
SE - Svezia 187
IT - Italia 158
FI - Finlandia 135
IE - Irlanda 95
TR - Turchia 86
CA - Canada 41
GB - Regno Unito 29
IN - India 26
BE - Belgio 20
IR - Iran 14
SG - Singapore 13
KR - Corea 11
CZ - Repubblica Ceca 8
EU - Europa 5
RU - Federazione Russa 5
FR - Francia 3
RO - Romania 3
TH - Thailandia 3
CL - Cile 2
NL - Olanda 2
TG - Togo 2
BR - Brasile 1
CH - Svizzera 1
LA - Repubblica Popolare Democratica del Laos 1
RS - Serbia 1
SD - Sudan 1
Totale 8.041
Città #
Fairfield 879
Ann Arbor 674
Woodbridge 647
Chandler 490
Houston 431
Ashburn 414
Wilmington 351
Jacksonville 347
Seattle 347
Cambridge 284
Dearborn 212
Beijing 99
Princeton 98
Dublin 95
Udine 87
Izmir 86
New York 58
San Diego 52
Des Moines 46
Boardman 32
Ottawa 30
Ogden 22
Brussels 20
Nanjing 17
San Mateo 15
Kunming 14
Singapore 13
Jinan 12
Falls Church 11
Leawood 11
Norwalk 10
Augusta 9
Monmouth Junction 9
Mumbai 9
Brno 8
Hefei 8
Nanchang 8
Trieste 7
Winnipeg 7
Guangzhou 6
Hebei 6
Munich 6
Grafing 5
Helsinki 5
Padova 5
Shanghai 5
Ardabil 4
Bologna 4
Changsha 4
Indiana 4
Simi Valley 4
Wenzhou 4
Wuhan 4
Andover 3
Chengdu 3
Livorno 3
Saint Petersburg 3
Shenyang 3
Velletri 3
Washington 3
Auburn Hills 2
Bangalore 2
Bangkok 2
Baotou 2
Fuzhou 2
Lomé 2
Los Angeles 2
Malborghetto 2
Milan 2
Montreal 2
Nanning 2
Naples 2
New Delhi 2
Rome 2
Shaoxing 2
Zanjan 2
Atlanta 1
Basiliano 1
Belgrade 1
Bucharest 1
Busswil 1
Campegine 1
Changchun 1
Chaoyang 1
Codroipo 1
Cornedo Vicentino 1
Edinburgh 1
Frankfurt am Main 1
Glendale 1
Gorizia 1
Greenville 1
Guidonia 1
Guiyang 1
Henderson 1
Leedey 1
Moncton 1
Ningbo 1
Nürnberg 1
Olevsk 1
Phoenix 1
Totale 6.112
Nome #
Educational and Organizational Interventions to Improve the Usefulness of Clinical Pharmacological Advice for Personalized Drug Dosing Based on Therapeutic Drug Monitoring. 148
Pharmacokinetics of two oral cyclosporin a formulations in clinically stable heart-transplant patients 140
C(2) monitoring of cyclosporine in stable heart transplant patients after two daily and three daily doses. 139
Clinical relevance of pharmacokinetics and pharmacodynamics in cardiac critical care patients 134
Cyclosporine A pharmacokinetics in rheumatoid arthritis patients after 6 months of methotrexate therapy 129
Chlorpromazine disposition in relation to age in children 128
Levofloxacin PK/PD: from sequential therapy model to high dosage for critical patients 128
No effect of clodronate on cyclosporin A blood levels in heart transplant patients simultaneously treated with diltiazem and azathioprine. 125
What should be the first-choice strategy to maximize posaconazole exposure in daily clinical practice? 120
Side effects of imipramine therapy in enuretic children. 118
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia. 116
Major role of levofloxacin in the treatment of a case of Listeria monocytogenes meningitis 111
Plasma levels of levodopa. Its main metabolites and carbidopa after conventional and slow release levodopa-carbidopa treatment in parkinsonian patients. 109
Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitis 108
Cyclosporin nephrotoxicity in relation to its metabolism in psoriasis 108
Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: a report of 2 cases. 107
Circadian variations in cyclosporine C2 concentrations during the first 2 weeks after liver transplantation. 106
Hyperlactacidemia Potentially Due to Linezolid Overexposure in a Liver Transplant Recipient 105
Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions 105
High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures 104
Therapeutic drug monitoring of lamotrigine in patients suffering from resistant partial seizures 104
Validation of limited sampling strategy for estimation of mycophenolic acid exposure during the first year after heart transplantation 103
Determination of tamoxifen and its metabolites in the endometrial tissue of long term treated women 103
Pharmacokinetics and pharmacodynamics of intravenous levofloxacin in patients with early-onset ventilator-associated pneumonia 102
A simple method to monitor serum concentrations of fluoxetine and its major metabolite for pharmacokinetic studies 101
Somatomedin C (insulin-like growth factor 1) levels decrease during acute changes of stress related hormones. Relevance for fibromyalgia. 101
Levofloxacin disposition in cerebrospinal fluid in patients with external ventriculostomy 101
Effect of fluctuations of blood cyclosporine concentrations on renal function. 100
Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis 99
Urinary Pharmacokinetics and Theoretical Pharmacodynamics of Intravenous Levofloxacin in Intensive Care Unit Patients Treated with 500 mg b.i.d. for Ventilator-Associated Pneumonia 99
Therapeutic mycophenolic acid monitoring by means of limited sampling strategy in orthotopic heart transplant patients 98
Calculating percentage prediction error: a user's note 97
Dosing nomograms for attaining optimum concentrations of meropenem by continuous infusion in critically ill patients with severe gram-negative infections: A pharmacokinetics/pharmacodynamics-based approach 97
Teicoplanin therapeutic drug monitoring in critically ill patients: A retrospective study emphasizing the importance of a loading dose 96
Treatment of pyogenic (non-tuberculous) spondylodiscitis with tailored high-dose levofloxacin plus rifampicin 96
Levofloxacin disposition over time in aqueous humor of patients undergoing cataract surgery 95
Ciprofloxacin disposition in elderly patients with LRTI being treated with sequential therapy (200 mg intravenously twice daily followed by 500 mg per os twice daily): Comparative pharmacokinetics and the role of therapeutic drug monitoring 95
Effect of the number of samples on bayesian and non-linear least-squares individualization: A study of cyclosporin treatment of haematological patients with multidrug resistance 94
Chronopharmacokinetics of ciclosporin and tacrolimus 90
Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia 90
Blood concentrations and clinical effect of cyclosporin in psoriasis 89
Pharmacokinetic drug interaction between everolimus and antifungal triazoles in a liver transplant patient 89
A SIMPLE METHOD TO MONITOR PLASMA CONCENTRATIONS OF OXCARBAZEPINE,CARBAMAZEPINE, THEIR MAIN METABOLITES AND LAMOTRIGINE IN EPILEPTIC PATIENTS 89
Acute oxcarbazepine, benazepril and hydrochlorothiazide overdose with alcohol 88
Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective 88
Multidrug resistance modulation in vivo. The effect of cyclosporin alone or with dextro-verapamil on idarubicin pharmacokinetics in acute leukemia 88
Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure 87
The effect of multifactorial, multidisciplinary educational interventions on appropriate use of teicoplanin 87
Penetration of levofloxacin into paranasal sinuses mucosa of patients with chronic rhinosinusitis after a single 500 mg oral dose 87
MEGX disposition in critically-ill trauma patients: Subsequent assessments during the first week following trauma 87
Successful long-term treatment of cerebral nocardiosis with unexpectedly low doses of linezolid in an immunocompromised patient receiving complex polytherapy 87
Is the use of vancomycin doses of at least 1 g every 8 hours the only way to achieve optimal trough levels in critically ill trauma patients with pneumonia and normal renal function? 86
Imipramine pharmacokinetics in depressed geriatric patients 86
Pharmacology of ifosfamide 85
A simple and sensitive HPLC method ti monitor serum and synovial fluid concnetrations of ketorolac in reumathologic patients 84
TDM coupled with Bayesian forecasting should be considered an invaluable tool for optimizing vancomycin daily exposure in unstable critically ill patients 84
Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy 82
Daunorubicin and daunorubicinol tissue concentrations in gastric cancer patients after local administration of a liposomal preparation 82
Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients 82
TDM-guided therapy with daptomycin and meropenem in a morbidly obese, critically ill patient 82
Cyclosporine dose fractioning might affect renal function in stable heart transplanted patients 81
Therapeutic drug monitoring-guided high teicoplanin dosage regimen required to treat a hypoalbuminemic renal transplant patient undergoing continuous venovenous hemofiltration 81
Pharmacokinetic and pharmacodynamic aspects of oral moxifloxacin 400 mg/day in elderly patients with acute exacerbation of chronic bronchitis 81
Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients 80
Isoniazid and its hydrazine metabolite in patients with tuberculosis 80
Inter-patient and intra-patient variations in the baseline tapping test in patients with Parkinson's disease 79
Pharmacokinetic-pharmacodynamic aspecte of antimicrobial prophylaxis with teisoplanin in patients undergoing major vascular surgery 79
Fluoxetine disposition in patients suffering from chronic hepatitis C treated with interferon alpha 77
Levodopa and 3-O-methyldopa in cerebrospinal fluid after levodopa-carbidopa association 74
Oral gabapentin disposition in patients with epilepsy after a high-protein meal 71
AM and PM C2 monitoring of cyclosporine in liver transplant recipients 71
Effects of different sampling strategies on predictions of blood cyclosporine concentrations in haematological patients with multidrug resistance by Bayesian and non-linear least squares methods 69
Is antimicrobial underexposure due to glomerular hyperfiltration a possible cause of increased mortality rate from bacterial infections in critically ill patients? 68
CYCLOSPORINE-A (CSA) PLUS CHEMOTHERAPY (CHT) IN-VIVO, TO OVERCOME MULTIDRUG-RESISTANCE (MDR) 66
Systemic vancomycin overexposure in a patient with spinal cord injury who had staphylococcal sepsis and Clostridium difficile colitis 65
Antimicrobial agents in elective surgery: Prophylaxis or "early therapy"? 63
Preliminary observations on serum concentrations of tamoxifen and its main metabolites in patients with breast cancer 61
Optimisation of vancomycin regimen in neutropenic haematological patients with normal renal function. Multiple daily doses may be preferable 57
CYCLOSPORINE-A PLUS CHEMOTHERAPY IN ACUTE MYELOID-LEUKEMIA 56
Pharmacokinetic aspects of levofloxacin 500 mg once-daily during sequential intravenous/oral therapy in patients with lower respiratory tract infections 56
Antimicrobial therapy in critically ill patients: A review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability 55
Oral and intravenous disposition of cyclosporine in psoriatic patients. 54
Nicotine and cotinine plasma concentrations: Useful markers to optimize nicotine replacement therapy in smokers 54
Tamoxifen and its main metabolites serum and tissue concentration in breast cancer women 53
Cyclosporin nephrotoxicity in relation to its pharmacokinetics in man 53
Monitoraggio del Gabapentine e della Lamotrigina in pazienti con crisi parziali complesse 51
Un caso di encefalite da Mycoplasma pneumoniae trattato con levofloxacina 49
Pharmacokinetic profile of two different administration schemes of teicoplanin. Single 400 mg intravenous dose vs double-refracted 200 mg intramuscular doses in healthy volunteers 48
FARMACOLOGIA CLINICA DELL'ENURESI PRIMARIA 45
Personalization of antimicrobial dosing regimens: Indicators of performance 45
Teicoplanin in patients with acute leukaemia and febrile neutropenia: a special population benefiting from higher dosages 40
Farmacologia generale e clinica per le lauree sanitarie - III Edizione - Ed. Piccin 39
P170-related multidrug resistance. Enhancement of idarubicin content in leukemic cells with cyclosporin in vivo: a report of two cases 39
Farmacologia - Principi e applicazioni 36
Variability in the metabolism of levodopa and clinical implications 36
Farmacologia generale e clinica per le lauree sanitarie - II edizione 35
Farmacologia generale e clinica per le lauree triennali 34
Drop in trough blood concentrations of tacrolimus after switching from nelfinavir to fosamprenavir in four HIV-infected liver transplant patients 28
Totale 8.277
Categoria #
all - tutte 25.006
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.006


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.282 130 78 87 379 172 380 270 240 175 168 37 166
2020/20211.279 52 162 21 166 67 157 48 137 173 49 181 66
2021/2022941 40 68 47 89 48 50 43 42 15 154 209 136
2022/20231.021 112 90 18 127 132 276 0 74 130 13 20 29
2023/2024319 55 23 7 5 60 72 6 19 36 6 2 28
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 8.277